EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 3.0

Thymidylate Synthase as a Predictive Biomarker for Pemetrexed Response in NSCLC

Ali A Bukhari, Ranjit K Goudar

Lung Cancer International · 2013

DOI: 10.1155/2013/436409 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Lung Cancer International, 2013. Verfasst von Ali A Bukhari und 1 weiteren Autor:innen. Beteiligte Einrichtung: Eastern Virginia Medical School, 700 West Olney Road Norfolk, Norfolk, VA 23507, USA. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In recent years, major strides in cancer research have made it possible to select personalized chemotherapy recommendations based on an individual patient’s tumor biology. The prognostic and/or predictive ability of biomarkers seeks to tailor the use of targeted chemotherapy and can result in improved clinical outcomes with reduced toxicity. A proliferation of new technology and pharmacotherapeutics in the setting of current FDA Clinical Laboratory Improvement Amendment (CLIA) standards has resulted in a recent surge in direct-to-physician biomarker tests. However, in the absence of clinical validation, there is the concern that the biomarkers may be utilized prematurely, resulting in improper chemotherapy selection and patient harm. Thymidylate synthase (TS) has been marketed as a predictive biomarker for the use of pemetrexed in NSCLC. We will examine the evidence behind the use of TS as a predictive biomarker to predict response to pemetrexed in NSCLC. At this time, the evidence does not currently support using TS assays to guide chemotherapy selection outside of a clinical research protocol.

Autor:innen und Institutionen

  • Eastern Virginia Medical School, 700 West Olney Road Norfolk, Norfolk, VA 23507, USA.
  • Virginia Oncology Associates, Eastern Virginia Medical School, 5900 Lake Wright Drive Norfolk, Norfolk, VA 23502, USA.

Zitieren

APA

Bukhari, A. A., & Goudar, R. K. (2013). Thymidylate Synthase as a Predictive Biomarker for Pemetrexed Response in NSCLC. Lung Cancer International. https://doi.org/10.1155/2013/436409

Vancouver

Bukhari AA, Goudar RK. Thymidylate Synthase as a Predictive Biomarker for Pemetrexed Response in NSCLC. Lung Cancer International. 2013. doi:10.1155/2013/436409

BibTeX
@article{Bukhari2013,
  author = {Bukhari, Ali A and Goudar, Ranjit K},
  title = {Thymidylate Synthase as a Predictive Biomarker for Pemetrexed Response in NSCLC},
  journal = {Lung Cancer International},
  year = {2013},
  doi = {10.1155/2013/436409}
}
Kostenlos starten →